XML 37 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2021
Sep. 30, 2020
Current    
Cash and cash equivalents $ 152,107,745 $ 29,249,018
Incentive and tax receivables 9,136,831 4,849,340
Prepaid expenses and deposits 355,549 443,839
Deferred financing charges 16,365 0
Total Assets 161,616,490 34,542,197
Current Liabilities    
Accounts payable 4,739,781 3,989,054
Accrued liabilities - Note 3 5,614,774 3,316,574
Deferred grant income 443,831 0
Total Liabilities 10,798,386 7,305,628
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized: 200,000,000 common stock, par value $0.001 per share (2020: 100,000,000 common stock, par value $0.001 per share) Issued and outstanding: 75,918,465 common shares (2020 - 62,045,198) 75,920 62,047
Additional paid-in capital 348,328,048 186,851,752
Accumulated deficit (197,585,864) (159,677,230)
Total Stockholders' Equity 150,818,104 27,236,569
Total Liabilities and Stockholders' Equity $ 161,616,490 $ 34,542,197